An Augmented Modulated Deep Learning Based Intelligent Predictive Model for Brain Tumor Detection Using GAN Ensemble.

PGGAN brain tumor deep learning generative adversarial network machine learning soft voting

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
03 Aug 2023
Historique:
received: 26 05 2023
revised: 25 07 2023
accepted: 28 07 2023
medline: 14 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Brain tumor detection in the initial stage is becoming an intricate task for clinicians worldwide. The diagnosis of brain tumor patients is rigorous in the later stages, which is a serious concern. Although there are related pragmatic clinical tools and multiple models based on machine learning (ML) for the effective diagnosis of patients, these models still provide less accuracy and take immense time for patient screening during the diagnosis process. Hence, there is still a need to develop a more precise model for more accurate screening of patients to detect brain tumors in the beginning stages and aid clinicians in diagnosis, making the brain tumor assessment more reliable. In this research, a performance analysis of the impact of different generative adversarial networks (GAN) on the early detection of brain tumors is presented. Based on it, a novel hybrid enhanced predictive convolution neural network (CNN) model using a hybrid GAN ensemble is proposed. Brain tumor image data is augmented using a GAN ensemble, which is fed for classification using a hybrid modulated CNN technique. The outcome is generated through a soft voting approach where the final prediction is based on the GAN, which computes the highest value for different performance metrics. This analysis demonstrated that evaluation with a progressive-growing generative adversarial network (PGGAN) architecture produced the best result. In the analysis, PGGAN outperformed others, computing the accuracy, precision, recall, F1-score, and negative predictive value (NPV) to be 98.85, 98.45%, 97.2%, 98.11%, and 98.09%, respectively. Additionally, a very low latency of 3.4 s is determined with PGGAN. The PGGAN model enhanced the overall performance of the identification of brain cell tissues in real time. Therefore, it may be inferred to suggest that brain tumor detection in patients using PGGAN augmentation with the proposed modulated CNN technique generates the optimum performance using the soft voting approach.

Identifiants

pubmed: 37571713
pii: s23156930
doi: 10.3390/s23156930
pmc: PMC10422344
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Multimed Tools Appl. 2023 Apr 25;:1-31
pubmed: 37362641
Sensors (Basel). 2022 Jan 04;22(1):
pubmed: 35009911
Front Comput Neurosci. 2022 Sep 02;16:1005617
pubmed: 36118133
Tomography. 2020 Jun;6(2):186-193
pubmed: 32548295
Comput Methods Programs Biomed. 2021 Mar;200:105797
pubmed: 33317871
Comput Math Methods Med. 2022 Jul 1;2022:2858845
pubmed: 35813426
Sensors (Basel). 2021 Mar 22;21(6):
pubmed: 33810176
Front Oncol. 2021 Jun 04;11:690244
pubmed: 34150660
Comput Math Methods Med. 2022 May 18;2022:8330833
pubmed: 35633922
J Imaging. 2022 Jul 22;8(8):
pubmed: 35893083
BMC Med Inform Decis Mak. 2023 Jan 23;23(1):16
pubmed: 36691030
Sci Rep. 2022 Sep 12;12(1):15331
pubmed: 36097024

Auteurs

Saswati Sahoo (S)

School of Computer Engineering, KIIT Deemed to be University, Bhubaneswar 751024, India.

Sushruta Mishra (S)

School of Computer Engineering, KIIT Deemed to be University, Bhubaneswar 751024, India.

Baidyanath Panda (B)

LTIMindtree, 1 American Row, 3rd Floor, Hartford, CT 06103, USA.

Akash Kumar Bhoi (AK)

Directorate of Research, Sikkim Manipal University, Gangtok 737102, India.
KIET Group of Institutions, Delhi-NCR, Ghaziabad 201206, India.
Institute of Information Science and Technologies, National Research Council, 56124 Pisa, Italy.

Paolo Barsocchi (P)

Institute of Information Science and Technologies, National Research Council, 56124 Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH